F-group (family)
2002.4.1.1 NAPRTase
Ligands and drugs
254
Member domains
84
with ligand contacts (≤ 4 Å)
33.1% of members
69
with DrugDomain annotations
27.2% of members
62
with a DrugBank compound
24.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2002.4.1.1 belongs to X-group 2002 TIM beta/alpha-barrel, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03227 | NMN | Nicotinamide Mononucleotide | 14 |
| DB01632 | PRP | 5-O-phosphono-alpha-D-ribofuranosyl diphosphate | 6 |
| DB12731 | DGB | Daporinad | 3 |
| DB02701 | NCA | Nicotinamide | 2 |
| DB03148 | A12 | Adenosine 5'-methylenediphosphate | 2 |
| DB19243 | 96Q | Padnarsertib | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | 16 |
| NCA | NICOTINAMIDE | 8 |
| MGmetal | MAGNESIUM ION | 7 |
| PRP | 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose | 6 |
| 7YX | N-[4-[(4R)-1-cyclopentyl-4-methyl-6-oxidanylidene-4,5-dihydropyridazin-3-yl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-2-carboxamide | 4 |
| BEF | BERYLLIUM TRIFLUORIDE ION | 4 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 4 |
| POP | PYROPHOSPHATE 2- | 4 |
| UNU | BENZAMIDE | 4 |
| CL | CHLORIDE ION | 3 |
| DGB | (2E)-N-{4-[1-(benzenecarbonyl)piperidin-4-yl]butyl}-3-(pyridin-3-yl)prop-2-enamide | 3 |
| 7T7 | N-[4-({[(3S)-oxolan-3-yl]methyl}carbamoyl)phenyl]-1,3-dihydro-2H-isoindole-2-carboxamide | 2 |
| 7YT | N-[4-[(4R)-1,4-dimethyl-6-oxidanylidene-4,5-dihydropyridazin-3-yl]phenyl]-5,7-dihydropyrrolo[3,4-b]pyridine-6-carboxamide | 2 |
| 8HV | 5-fluoro-N-{4-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]phenyl}-2H-isoindole-2-carboxamide | 2 |
| 8HY | N-{4-[(3-phenylpropyl)carbamoyl]phenyl}-2H-isoindole-2-carboxamide | 2 |
| 9IY | [(2~{R},3~{S},4~{R},5~{S})-3,4-bis(oxidanyl)-5-[4-[[[4-(phenylsulfonyl)phenyl]carbamoylamino]methyl]phenyl]oxolan-2-yl]methyl dihydrogen phosphate | 2 |
| A12 | PHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER | 2 |
| A1D52 | (13~{a}~{S})-6,7-dimethoxy-9,11,12,13,13~{a},14-hexahydrophenanthro[9,10-f]indolizin-3-ol | 2 |
| IS1 | 3-[(1E)-3-oxo-3-({4-[1-(phenylcarbonyl)piperidin-4-yl]butyl}amino)prop-1-en-1-yl]-1-beta-D-ribofuranosylpyridinium | 2 |
| 1LJ | 1-[(6-aminopyridin-3-yl)methyl]-3-[4-(phenylsulfonyl)phenyl]urea | 1 |